[
  {
    "title": "恩华药业控股股东恩华投资质押1620.23万股 用于融资担保",
    "href": "http://stock.jrj.com.cn/2023/01/06191137265149.shtml",
    "datetime": "2023-01-06 19:11:34",
    "code": "002262"
  },
  {
    "title": "恩华药业：从丹麦灵北引进的1类创新药NHL35700片获批临床试验",
    "href": "http://stock.jrj.com.cn/2022/12/29211537247799.shtml",
    "datetime": "2022-12-29 21:15:13",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：NHL35700获批开展精神分裂症的临床试验",
    "href": "http://stock.jrj.com.cn/2022/12/29115237245722.shtml",
    "datetime": "2022-12-29 11:52:49",
    "code": "002262"
  },
  {
    "title": "恩华药业：在研创新药NH130枸橼酸盐片获批临床试验 拟用于治疗帕金森病精神病",
    "href": "http://stock.jrj.com.cn/2022/12/20071237224363.shtml",
    "datetime": "2022-12-20 07:12:53",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：1类化学药品NH130枸橼酸盐片获批开展临床试验",
    "href": "http://stock.jrj.com.cn/2022/12/19162737222634.shtml",
    "datetime": "2022-12-19 16:27:14",
    "code": "002262"
  },
  {
    "title": "恩华药业与绿叶制药、好心情达成战略合作 加速推进抗抑郁创新药若欣林商业化布局",
    "href": "http://stock.jrj.com.cn/2022/12/01173337182033.shtml",
    "datetime": "2022-12-01 17:33:31",
    "code": "002262"
  },
  {
    "title": "恩华药业2022年前三季度净利7.42亿同比增长10.25% 资产减值损失同比减少",
    "href": "http://stock.jrj.com.cn/2022/10/26205137087290.shtml",
    "datetime": "2022-10-26 20:51:05",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)第三季度净利2.94亿元 同比增长12.35%",
    "href": "http://stock.jrj.com.cn/2022/10/26163537085829.shtml",
    "datetime": "2022-10-26 16:35:00",
    "code": "002262"
  },
  {
    "title": "恩华药业：氟马西尼注射液通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/10/10165037044413.shtml",
    "datetime": "2022-10-10 16:50:00",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：氟马西尼注射液通过一致性评价",
    "href": "http://stock.jrj.com.cn/2022/10/10115037043286.shtml",
    "datetime": "2022-10-10 11:50:12",
    "code": "002262"
  },
  {
    "title": "恩华药业：获得奥氮平片《药品注册证书》",
    "href": "http://stock.jrj.com.cn/2022/08/12164336895328.shtml",
    "datetime": "2022-08-12 16:43:56",
    "code": "002262"
  },
  {
    "title": "A股异动 | 利好叠加 恩华药业(002262.SZ)续涨5%",
    "href": "http://stock.jrj.com.cn/2022/08/08132636878446.shtml",
    "datetime": "2022-08-08 13:26:56",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：原料药非诺贝特通过日本PMDA认证",
    "href": "http://stock.jrj.com.cn/2022/08/03155136866805.shtml",
    "datetime": "2022-08-03 15:51:18",
    "code": "002262"
  },
  {
    "title": "恩华药业披露2022年半年报，实现营收20.01亿元",
    "href": "http://stock.jrj.com.cn/2022/08/01132636858728.shtml",
    "datetime": "2022-08-01 13:26:46",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：为了引进并留住经营管理人才、拟转让远恒药业13%股权予王泽宇",
    "href": "http://stock.jrj.com.cn/2022/07/30150036856060.shtml",
    "datetime": "2022-07-30 15:00:58",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)半年度净利润4.48亿元、同比增长8.91%",
    "href": "http://stock.jrj.com.cn/2022/07/29181436854682.shtml",
    "datetime": "2022-07-29 18:14:27",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：上海恩元十四款体外诊断试剂盒近期同时完成欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2022/06/28164836764705.shtml",
    "datetime": "2022-06-28 16:48:25",
    "code": "002262"
  },
  {
    "title": "恩华药业控股股东恩华投资质押970万股 用于融资担保",
    "href": "http://stock.jrj.com.cn/2022/06/09193136716890.shtml",
    "datetime": "2022-06-09 19:31:33",
    "code": "002262"
  },
  {
    "title": "恩华药业控股股东恩华投资质押1000万股 用于融资担保",
    "href": "http://stock.jrj.com.cn/2022/05/20191036666805.shtml",
    "datetime": "2022-05-20 19:10:51",
    "code": "002262"
  },
  {
    "title": "恩华药业：股东恩华投资所持1000万股被质押 占公司总股本比例0.99%",
    "href": "http://stock.jrj.com.cn/2022/05/20132536665312.shtml",
    "datetime": "2022-05-20 13:25:11",
    "code": "002262"
  },
  {
    "title": "恩华药业续聘段保州担任公司副总经理 2021年度公司净利7.98亿",
    "href": "http://stock.jrj.com.cn/2022/05/12213236644354.shtml",
    "datetime": "2022-05-12 21:32:51",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：2021年年度权益分派10派2元 股权登记日5月12日",
    "href": "http://stock.jrj.com.cn/2022/05/05172836570694.shtml",
    "datetime": "2022-05-05 17:28:59",
    "code": "002262"
  },
  {
    "title": "恩华药业2022年第一季度净利1.89亿同比增长12.45% 理财收益增加",
    "href": "http://stock.jrj.com.cn/2022/04/23155136437156.shtml",
    "datetime": "2022-04-23 15:51:27",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：一季度净利升12.45%至1.89亿元",
    "href": "http://stock.jrj.com.cn/2022/04/22154236428565.shtml",
    "datetime": "2022-04-22 15:42:45",
    "code": "002262"
  },
  {
    "title": "恩华药业：子公司苏州恩华通过高新技术企业认定",
    "href": "http://stock.jrj.com.cn/2022/04/19135936397825.shtml",
    "datetime": "2022-04-19 13:59:03",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：子公司苏州恩华通过高新技术企业认定",
    "href": "http://stock.jrj.com.cn/2022/04/19114636396175.shtml",
    "datetime": "2022-04-19 11:46:20",
    "code": "002262"
  },
  {
    "title": "恩华药业：获得《药品注册证书》 有助于丰富公司在麻醉领域产品管线",
    "href": "http://stock.jrj.com.cn/2022/04/18165936385990.shtml",
    "datetime": "2022-04-18 16:59:07",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：化学药品盐酸咪达唑仑口服溶液获批上市",
    "href": "http://stock.jrj.com.cn/2022/04/18161036384437.shtml",
    "datetime": "2022-04-18 16:10:34",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：北京医华真轻松互联网医院取得医疗机构执业许可证",
    "href": "http://stock.jrj.com.cn/2022/04/13115936322037.shtml",
    "datetime": "2022-04-13 11:59:20",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：获董事长孙彭生增持28.36万股",
    "href": "http://stock.jrj.com.cn/2022/03/30163336197271.shtml",
    "datetime": "2022-03-30 16:33:26",
    "code": "002262"
  },
  {
    "title": "恩华药业2021年净利7.98亿同比增长9.46% 董事长孙彭生薪酬25万",
    "href": "http://stock.jrj.com.cn/2022/03/26051335220895.shtml",
    "datetime": "2022-03-26 05:13:00",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)2021年度净利升9.46%至7.98亿元 拟10派2元",
    "href": "http://stock.jrj.com.cn/2022/03/25182835129800.shtml",
    "datetime": "2022-03-25 18:28:15",
    "code": "002262"
  },
  {
    "title": "恩华药业控股股东恩华投资质押3100万股 用于融资担保",
    "href": "http://stock.jrj.com.cn/2022/03/15183234830218.shtml",
    "datetime": "2022-03-15 18:32:19",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：恩华投资质押3100万股",
    "href": "http://stock.jrj.com.cn/2022/03/15160734829165.shtml",
    "datetime": "2022-03-15 16:07:50",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：恩华投资解除质押2250万股",
    "href": "http://stock.jrj.com.cn/2022/03/08155334541264.shtml",
    "datetime": "2022-03-08 15:53:42",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：恩华投资解除质押1560万股",
    "href": "http://stock.jrj.com.cn/2022/03/01160734508144.shtml",
    "datetime": "2022-03-01 16:07:06",
    "code": "002262"
  },
  {
    "title": "恩华药业2021年净利7.98亿同比增长9.48% 新上市产品推广力度加大",
    "href": "http://stock.jrj.com.cn/2022/02/25191234465645.shtml",
    "datetime": "2022-02-25 19:12:33",
    "code": "002262"
  },
  {
    "title": "恩华药业控股股东恩华投资质押1950万股 用于融资担保",
    "href": "http://stock.jrj.com.cn/2022/02/23201234447843.shtml",
    "datetime": "2022-02-23 20:12:05",
    "code": "002262"
  },
  {
    "title": "恩华药业控股股东恩华投资质押2000万股 用于融资担保",
    "href": "http://stock.jrj.com.cn/2022/02/15191134354851.shtml",
    "datetime": "2022-02-15 19:11:13",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：恩华投资质押2000万股",
    "href": "http://stock.jrj.com.cn/2022/02/15170934354178.shtml",
    "datetime": "2022-02-15 17:09:13",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：奥赛利定富马酸盐注射液(TRV130)上市许可申请获得受理",
    "href": "http://stock.jrj.com.cn/2022/01/27211834234257.shtml",
    "datetime": "2022-01-27 21:18:49",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：注射用盐酸瑞芬太尼新增适应症获批临床",
    "href": "http://stock.jrj.com.cn/2021/12/30115534086112.shtml",
    "datetime": "2021-12-30 11:55:44",
    "code": "002262"
  },
  {
    "title": "恩华药业：预计NH600001乳状注射液会有超过10亿以上的市场空间",
    "href": "http://stock.jrj.com.cn/2021/12/14145934014219.shtml",
    "datetime": "2021-12-14 14:59:06",
    "code": "002262"
  },
  {
    "title": "恩华药业：NH600001乳状注射液获得药物临床试验批准通知书",
    "href": "http://stock.jrj.com.cn/2021/12/13135134008308.shtml",
    "datetime": "2021-12-13 13:51:18",
    "code": "002262"
  },
  {
    "title": "恩华药业收到1类化学药品《药物临床试验批准通知书》",
    "href": "http://stock.jrj.com.cn/2021/12/13121034007772.shtml",
    "datetime": "2021-12-13 12:10:57",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：1类化学药品NH600001乳状注射液获批临床",
    "href": "http://stock.jrj.com.cn/2021/12/13114734007679.shtml",
    "datetime": "2021-12-13 11:47:53",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：与灵北就抗精神分裂症药物LuAF35700在大中华区达成独家许可协议",
    "href": "http://stock.jrj.com.cn/2021/11/25154633918884.shtml",
    "datetime": "2021-11-25 15:46:17",
    "code": "002262"
  },
  {
    "title": "A股异动 | 恩华药业涨8% 盐酸阿芬太尼注射液获得《药品注册证书》",
    "href": "http://stock.jrj.com.cn/2021/11/12095033839967.shtml",
    "datetime": "2021-11-12 09:50:42",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：获得盐酸阿芬太尼注射液2个规格的药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/11/11170333836746.shtml",
    "datetime": "2021-11-11 17:03:42",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：江苏好欣晴获东方明珠传媒产业基金增资1亿元",
    "href": "http://stock.jrj.com.cn/2021/10/26085233752564.shtml",
    "datetime": "2021-10-26 08:52:14",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)第三季度净利润2.62亿元 同比增长19.85%",
    "href": "http://stock.jrj.com.cn/2021/10/25183933748740.shtml",
    "datetime": "2021-10-25 18:39:24",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：恩华投资质押380万股",
    "href": "http://stock.jrj.com.cn/2021/10/22213933735656.shtml",
    "datetime": "2021-10-22 21:39:18",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：拟设立北京分公司",
    "href": "http://stock.jrj.com.cn/2021/09/09185533410707.shtml",
    "datetime": "2021-09-09 18:55:47",
    "code": "002262"
  },
  {
    "title": "恩华药业：为加快业务发展 参股公司江苏好欣晴拟增资2亿元",
    "href": "http://stock.jrj.com.cn/2021/09/06140933391932.shtml",
    "datetime": "2021-09-06 14:09:08",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：参股公司江苏好欣晴定增引入量子跃动、复星等国内顶级投资机构",
    "href": "http://stock.jrj.com.cn/2021/09/06120833391472.shtml",
    "datetime": "2021-09-06 12:08:13",
    "code": "002262"
  },
  {
    "title": "恩华药业控股股东恩华投资质押1840万股 用于融资担保",
    "href": "http://stock.jrj.com.cn/2021/08/24202933311733.shtml",
    "datetime": "2021-08-24 20:29:34",
    "code": "002262"
  },
  {
    "title": "恩华药业2021年上半年净利4.11亿增长16.46% 产品销售提升",
    "href": "http://stock.jrj.com.cn/2021/07/30235233177585.shtml",
    "datetime": "2021-07-30 23:52:32",
    "code": "002262"
  },
  {
    "title": "恩华药业：上半年营收增长25.81%，净利润增长16.46%",
    "href": "http://stock.jrj.com.cn/2021/07/30195633177006.shtml",
    "datetime": "2021-07-30 19:56:01",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)半年度净利润升16.46%至4.11亿元",
    "href": "http://stock.jrj.com.cn/2021/07/30192833176617.shtml",
    "datetime": "2021-07-30 19:28:33",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：与Complix就中枢神经领域药物研发事宜进行商谈并签署开发与许可协议",
    "href": "http://stock.jrj.com.cn/2021/07/28155933164107.shtml",
    "datetime": "2021-07-28 15:59:41",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：Protollin获得FDA药品临床试验批准",
    "href": "http://stock.jrj.com.cn/2021/07/22154733135301.shtml",
    "datetime": "2021-07-22 15:47:53",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：385.428万股限制性股票将解锁上市流通",
    "href": "http://stock.jrj.com.cn/2021/07/06170333053482.shtml",
    "datetime": "2021-07-06 17:03:41",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：大股东恩华投资解押810万股",
    "href": "http://stock.jrj.com.cn/2021/07/01185833028627.shtml",
    "datetime": "2021-07-01 18:58:08",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：注射用盐酸瑞芬太尼通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/06/29121433015148.shtml",
    "datetime": "2021-06-29 12:14:06",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：385.428万股限制性股票可解除限售",
    "href": "http://stock.jrj.com.cn/2021/06/25161132996608.shtml",
    "datetime": "2021-06-25 16:11:36",
    "code": "002262"
  },
  {
    "title": "恩华药业：公司的创新药物目前尚在研发中",
    "href": "http://stock.jrj.com.cn/2021/06/24213432991872.shtml",
    "datetime": "2021-06-24 21:34:07",
    "code": "002262"
  },
  {
    "title": "恩华药业：2021年的研发费用投入预计同比会有较大增幅",
    "href": "http://stock.jrj.com.cn/2021/06/23161532983234.shtml",
    "datetime": "2021-06-23 16:15:00",
    "code": "002262"
  },
  {
    "title": "恩华药业：聚焦中枢神经药物的研发和经营麻醉类产品线布局较完整可以广泛应用于医疗手术的各个场景",
    "href": "http://stock.jrj.com.cn/2021/06/23161432983237.shtml",
    "datetime": "2021-06-23 16:14:21",
    "code": "002262"
  },
  {
    "title": "恩华药业：公司子公司恩华赛德主要从事高血压、心力衰竭、脑卒中、动脉粥样硬化等心血管药物的开发生产销售",
    "href": "http://stock.jrj.com.cn/2021/06/21101032967823.shtml",
    "datetime": "2021-06-21 10:10:58",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：盐酸度洛西汀肠溶胶囊3个规格获批上市",
    "href": "http://stock.jrj.com.cn/2021/06/18115532953545.shtml",
    "datetime": "2021-06-18 11:55:43",
    "code": "002262"
  },
  {
    "title": "恩华药业：公司控股子公司远恒药业的实验室是其固有常设实验机构",
    "href": "http://stock.jrj.com.cn/2021/06/17210432949705.shtml",
    "datetime": "2021-06-17 21:04:54",
    "code": "002262"
  },
  {
    "title": "恩华药业：公司销售业务量同比有较大增幅存货相应增加",
    "href": "http://stock.jrj.com.cn/2021/06/01182632858257.shtml",
    "datetime": "2021-06-01 18:26:09",
    "code": "002262"
  },
  {
    "title": "恩华药业：股东部分股份解除质押",
    "href": "http://stock.jrj.com.cn/2021/06/01162632857304.shtml",
    "datetime": "2021-06-01 16:26:45",
    "code": "002262"
  },
  {
    "title": "恩华药业：公司去年营业收入同比下降的主要原因是转让原控股子公司恩华和润的部分股权给南京医药",
    "href": "http://stock.jrj.com.cn/2021/06/01102432855299.shtml",
    "datetime": "2021-06-01 10:24:51",
    "code": "002262"
  },
  {
    "title": "恩华药业质押公告出现多处低级错误：股东恩华投资质押股份数量达到6210亿股",
    "href": "http://stock.jrj.com.cn/2021/05/31191432851746.shtml",
    "datetime": "2021-05-31 19:14:53",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：恩华投资质押6210万股",
    "href": "http://stock.jrj.com.cn/2021/05/31155932850010.shtml",
    "datetime": "2021-05-31 15:59:39",
    "code": "002262"
  },
  {
    "title": "恩华药业：部分限制性股票回购注销完成",
    "href": "http://stock.jrj.com.cn/2021/05/25170032817252.shtml",
    "datetime": "2021-05-25 17:00:59",
    "code": "002262"
  },
  {
    "title": "恩华药业：2020年年度权益分派实施 每10股派发现金红利1.0元（含税）",
    "href": "http://stock.jrj.com.cn/2021/05/25170032817251.shtml",
    "datetime": "2021-05-25 17:00:59",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)2020年度权益分派10派1元 股权登记日为6月1日",
    "href": "http://stock.jrj.com.cn/2021/05/25165132816954.shtml",
    "datetime": "2021-05-25 16:51:40",
    "code": "002262"
  },
  {
    "title": "恩华药业：公司涉及第五轮国家集采的产品为阿立派唑片",
    "href": "http://stock.jrj.com.cn/2021/05/10121132728046.shtml",
    "datetime": "2021-05-10 12:11:45",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：氯硝西泮片国内首家通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/05/10120032727974.shtml",
    "datetime": "2021-05-10 12:00:31",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)一季度净利升21.68%至1.68亿元",
    "href": "http://stock.jrj.com.cn/2021/04/29000932475070.shtml",
    "datetime": "2021-04-29 00:09:13",
    "code": "002262"
  },
  {
    "title": "恩华药业：2020年度不再将恩华和润纳入合并报表范围",
    "href": "http://stock.jrj.com.cn/2021/04/26143832453743.shtml",
    "datetime": "2021-04-26 14:38:06",
    "code": "002262"
  },
  {
    "title": "恩华药业：公司聚焦中枢神经药物的研发和经营 其中麻醉类产品线布局较完整",
    "href": "http://stock.jrj.com.cn/2021/04/26101932452330.shtml",
    "datetime": "2021-04-26 10:19:36",
    "code": "002262"
  },
  {
    "title": "恩华药业：公司产品思贝格盐酸齐拉西酮胶囊对治疗急性精神分裂有良好的效果",
    "href": "http://stock.jrj.com.cn/2021/04/20120232408894.shtml",
    "datetime": "2021-04-20 12:02:05",
    "code": "002262"
  },
  {
    "title": "恩华药业：公司的麻醉药及精神药产品通过销售给医药商业公司",
    "href": "http://stock.jrj.com.cn/2021/03/29112132239631.shtml",
    "datetime": "2021-03-29 11:21:52",
    "code": "002262"
  },
  {
    "title": "恩华药业：公司2020年度年报的的纸质版本尚未印刷好",
    "href": "http://stock.jrj.com.cn/2021/03/25150832215567.shtml",
    "datetime": "2021-03-25 15:08:06",
    "code": "002262"
  },
  {
    "title": "恩华药业：盐酸戊乙奎醚及注射液不是精麻管制产品",
    "href": "http://stock.jrj.com.cn/2021/03/25144232215437.shtml",
    "datetime": "2021-03-25 14:42:31",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：阿立哌唑片通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/03/18160032157163.shtml",
    "datetime": "2021-03-18 16:00:51",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)通过高新技术企业复审",
    "href": "http://stock.jrj.com.cn/2021/03/18155932157151.shtml",
    "datetime": "2021-03-18 15:59:55",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：1类化药NH102盐酸盐片获批临床试验",
    "href": "http://stock.jrj.com.cn/2021/03/15120032135320.shtml",
    "datetime": "2021-03-15 12:00:01",
    "code": "002262"
  },
  {
    "title": "恩华药业2020年净利7.29亿增长9.88% 董事长孙彭生薪酬25万",
    "href": "http://stock.jrj.com.cn/2021/03/11215432111170.shtml",
    "datetime": "2021-03-11 21:54:18",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：拟使用不超18亿元部分闲置自有资金进行现金理财",
    "href": "http://stock.jrj.com.cn/2021/03/11201132110828.shtml",
    "datetime": "2021-03-11 20:11:43",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)董事会批准2021年度财务预算报告",
    "href": "http://stock.jrj.com.cn/2021/03/11201032110825.shtml",
    "datetime": "2021-03-11 20:10:53",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)2020年度净利润升9.88%至7.29亿元 拟10派1元",
    "href": "http://stock.jrj.com.cn/2021/03/11200632110814.shtml",
    "datetime": "2021-03-11 20:06:01",
    "code": "002262"
  },
  {
    "title": "恩华药业2020年度净利7.28亿 比上年同期增长9.8%",
    "href": "http://stock.jrj.com.cn/2021/02/26212032035414.shtml",
    "datetime": "2021-02-26 21:20:00",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)业绩快报：2020年净利升9.80%至7.28亿元",
    "href": "http://stock.jrj.com.cn/2021/02/26171932033710.shtml",
    "datetime": "2021-02-26 17:19:26",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)获得盐酸羟考酮注射液3个规格《药品注册证书》",
    "href": "http://stock.jrj.com.cn/2021/02/25164732026037.shtml",
    "datetime": "2021-02-25 16:47:30",
    "code": "002262"
  },
  {
    "title": "恩华药业：公司的销售费用率与同行业公司水平相当",
    "href": "http://stock.jrj.com.cn/2021/02/08165031870728.shtml",
    "datetime": "2021-02-08 16:50:39",
    "code": "002262"
  },
  {
    "title": "恩华药业：公司在上海、苏州和徐州均建有研发中心可以满足高端人才的需求",
    "href": "http://stock.jrj.com.cn/2021/01/22092931742784.shtml",
    "datetime": "2021-01-22 09:29:49",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：盐酸右美托咪定注射液通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/01/19170331722387.shtml",
    "datetime": "2021-01-19 17:03:23",
    "code": "002262"
  },
  {
    "title": "恩华药业：公司应付账款和应付票据项目整体下降是由于不再将“恩华和润”纳入合并报表范围所致",
    "href": "http://stock.jrj.com.cn/2021/01/18103431713685.shtml",
    "datetime": "2021-01-18 10:34:41",
    "code": "002262"
  },
  {
    "title": "恩华药业：2019年财报现金流量表附表中的经营性应收项目负值原因是其中有购买结构性存款4.5亿未到期",
    "href": "http://stock.jrj.com.cn/2021/01/08184531656884.shtml",
    "datetime": "2021-01-08 18:45:28",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：注射用甲磺酸齐拉西酮医保支付限定调整",
    "href": "http://stock.jrj.com.cn/2020/12/29122531594364.shtml",
    "datetime": "2020-12-29 12:25:34",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：与I-Mab US共同作为被许可方 与BWH、BDX就合作开发Protollin签署许可协议",
    "href": "http://stock.jrj.com.cn/2020/12/28160531586595.shtml",
    "datetime": "2020-12-28 16:05:11",
    "code": "002262"
  },
  {
    "title": "恩华药业：公司各项业务处于成长期 推广新产品 开拓市场份额都需要销售费用的投入",
    "href": "http://stock.jrj.com.cn/2020/12/25161231570522.shtml",
    "datetime": "2020-12-25 16:12:18",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：咪达唑仑注射液首家通过一致性评价",
    "href": "http://stock.jrj.com.cn/2020/12/17153831509509.shtml",
    "datetime": "2020-12-17 15:38:12",
    "code": "002262"
  },
  {
    "title": "恩华药业：TRV-130是一种新型小分子G蛋白偏向性配体曾被美国FDA授予突破性疗法认定",
    "href": "http://stock.jrj.com.cn/2020/12/17141631509038.shtml",
    "datetime": "2020-12-17 14:16:39",
    "code": "002262"
  },
  {
    "title": "恩华药业：TRV-130由Trevena公司在美国发现和开发 公司拥有TRV-130在中国开发和商业化的独家许可权利",
    "href": "http://stock.jrj.com.cn/2020/12/17141331509017.shtml",
    "datetime": "2020-12-17 14:13:59",
    "code": "002262"
  },
  {
    "title": "恩华药业(002262.SZ)：获得枸橼酸舒芬太尼注射液4个规格的药品注册证书",
    "href": "http://stock.jrj.com.cn/2020/12/09183831450575.shtml",
    "datetime": "2020-12-09 18:38:07",
    "code": "002262"
  },
  {
    "title": "[恩华药业]公司获江苏省“双创计划”团队资助",
    "href": "http://stock.jrj.com.cn/2020/11/23000031337262.shtml",
    "datetime": "2020-11-23 00:00:00",
    "code": "002262"
  },
  {
    "title": "恩华药业将花不超2亿元回购公司股份 用于减少注册资本",
    "href": "http://stock.jrj.com.cn/2020/11/18190431309357.shtml",
    "datetime": "2020-11-18 19:04:48",
    "code": "002262"
  },
  {
    "title": "恩华药业2020年前三季度净利5.71亿增长9.73% 股权激励费用减少",
    "href": "http://stock.jrj.com.cn/2020/10/26112331131894.shtml",
    "datetime": "2020-10-26 11:23:27",
    "code": "002262"
  },
  {
    "title": "恩华药业：2020年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/10/25205031123645.shtml",
    "datetime": "2020-10-25 20:50:00",
    "code": "002262"
  },
  {
    "title": "【龙虎榜】恩华药业8月10日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/08/10180730467117.shtml",
    "datetime": "2020-08-10 18:07:14",
    "code": "002262"
  },
  {
    "title": "恩华药业拟引进的急性镇痛类创新药获FDA批准上市",
    "href": "http://stock.jrj.com.cn/2020/08/10100530463923.shtml",
    "datetime": "2020-08-10 10:05:53",
    "code": "002262"
  },
  {
    "title": "恩华药业：2020年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/07/31161030393905.shtml",
    "datetime": "2020-07-31 16:10:00",
    "code": "002262"
  },
  {
    "title": "恩华药业2020年上半年净利3.53亿增长9.64% 管理费用同比下滑",
    "href": "http://stock.jrj.com.cn/2020/07/30230530387900.shtml",
    "datetime": "2020-07-30 23:05:21",
    "code": "002262"
  },
  {
    "title": "恩华药业股东恩华投资质押3060万股 用于融资担保",
    "href": "http://stock.jrj.com.cn/2020/07/01192330113197.shtml",
    "datetime": "2020-07-01 19:23:16",
    "code": "002262"
  },
  {
    "title": "恩华药业股东恩华投资质押1.63亿股 用于融资担保",
    "href": "http://stock.jrj.com.cn/2020/06/09191629882719.shtml",
    "datetime": "2020-06-09 19:16:21",
    "code": "002262"
  },
  {
    "title": "[恩华药业]我公司专利项目获首届徐州市专利金奖",
    "href": "http://stock.jrj.com.cn/2020/06/09000029879963.shtml",
    "datetime": "2020-06-09 00:00:00",
    "code": "002262"
  },
  {
    "title": "新药进入放量期 恩华药业第一主业年复合增长超20%推动业绩“十连增”",
    "href": "http://stock.jrj.com.cn/2020/05/21092929729572.shtml",
    "datetime": "2020-05-21 09:29:00",
    "code": "002262"
  },
  {
    "title": "恩华药业：为加快业务发展 参股子公司江苏好欣晴拟引入新股东融资1.25亿元",
    "href": "http://stock.jrj.com.cn/2020/05/07153929610071.shtml",
    "datetime": "2020-05-07 15:39:01",
    "code": "002262"
  },
  {
    "title": "恩华药业第一季度盈利1.38亿同比增长9.62% 股权激励费用减少",
    "href": "http://stock.jrj.com.cn/2020/04/27130229394341.shtml",
    "datetime": "2020-04-27 13:02:31",
    "code": "002262"
  },
  {
    "title": "恩华药业：2020年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/04/27101029393498.shtml",
    "datetime": "2020-04-27 10:10:00",
    "code": "002262"
  },
  {
    "title": "恩华药业：枸橼酸芬太尼口腔黏膜贴片获临床试验通知 若进展顺利将有望丰富公司产品线",
    "href": "http://stock.jrj.com.cn/2020/04/22164029349253.shtml",
    "datetime": "2020-04-22 16:40:36",
    "code": "002262"
  },
  {
    "title": "恩华药业：收到临床试验通知书",
    "href": "http://stock.jrj.com.cn/2020/04/22154329348939.shtml",
    "datetime": "2020-04-22 15:43:00",
    "code": "002262"
  },
  {
    "title": "[恩华药业]公司荣获2019年度“徐州市市长质量奖”",
    "href": "http://stock.jrj.com.cn/2020/04/21000029341224.shtml",
    "datetime": "2020-04-21 00:00:00",
    "code": "002262"
  },
  {
    "title": "证金、汇金去年四季度新进持有黔源电力、恩华药业等个股",
    "href": "http://stock.jrj.com.cn/2020/04/16115829303670.shtml",
    "datetime": "2020-04-16 11:58:00",
    "code": "002262"
  },
  {
    "title": "恩华药业拟使用不超过人民币15亿元的部分闲置自有资金投资理财产品",
    "href": "http://stock.jrj.com.cn/2020/03/27232029130888.shtml",
    "datetime": "2020-03-27 23:20:44",
    "code": "002262"
  },
  {
    "title": "恩华药业2019年度盈利6.63亿增长26%",
    "href": "http://stock.jrj.com.cn/2020/02/26182128898406.shtml",
    "datetime": "2020-02-26 18:21:12",
    "code": "002262"
  },
  {
    "title": "[恩华药业]抗击疫情,恩华一直在行动 徐州市委书记周铁根莅临恩华药业调研检查疫情防控和企业复工复产",
    "href": "http://stock.jrj.com.cn/2020/02/17000030647865.shtml",
    "datetime": "2020-02-17 00:00:00",
    "code": "002262"
  },
  {
    "title": "[恩华药业]击疫情,恩华一直在行动 徐州市委书记周铁根莅临恩华药业调研检查疫情防控和企业复工复产",
    "href": "http://stock.jrj.com.cn/2020/02/17000028838871.shtml",
    "datetime": "2020-02-17 00:00:00",
    "code": "002262"
  },
  {
    "title": "[恩华药业]抗击疫情,恩华一直在行动 市委常委、经开区党工委书记王强莅临我司调研检查复工后疫情防控工作",
    "href": "http://stock.jrj.com.cn/2020/02/17000028838872.shtml",
    "datetime": "2020-02-17 00:00:00",
    "code": "002262"
  },
  {
    "title": "[恩华药业]抗击疫情,恩华一直在行动",
    "href": "http://stock.jrj.com.cn/2020/02/13000028822023.shtml",
    "datetime": "2020-02-13 00:00:00",
    "code": "002262"
  },
  {
    "title": "[恩华药业]抗击疫情,恩华一直在行动 徐州市委副书记一行莅临恩华督导调研",
    "href": "http://stock.jrj.com.cn/2020/02/13000028822024.shtml",
    "datetime": "2020-02-13 00:00:00",
    "code": "002262"
  },
  {
    "title": "[恩华药业]抗击疫情,恩华一直在行动 恩华药业向徐州市红十字会捐赠防护用品",
    "href": "http://stock.jrj.com.cn/2020/02/10000028822025.shtml",
    "datetime": "2020-02-10 00:00:00",
    "code": "002262"
  },
  {
    "title": "[恩华药业]抗击疫情,恩华一直在行动 恩华药业向徐州市贾汪区疫情防控应急指挥部办公室捐赠防疫物资",
    "href": "http://stock.jrj.com.cn/2020/02/10000028822022.shtml",
    "datetime": "2020-02-10 00:00:00",
    "code": "002262"
  },
  {
    "title": "[恩华药业]抗击疫情,恩华一直在行动 恩华药业向徐州市公安局禁毒支队捐赠疫情防护用品",
    "href": "http://stock.jrj.com.cn/2020/02/10000028822021.shtml",
    "datetime": "2020-02-10 00:00:00",
    "code": "002262"
  },
  {
    "title": "恩华药业：捐赠价值202万元的药品",
    "href": "http://stock.jrj.com.cn/2020/02/06155728784314.shtml",
    "datetime": "2020-02-06 15:57:00",
    "code": "002262"
  },
  {
    "title": "恩华药业获得《药品注册批件》",
    "href": "http://stock.jrj.com.cn/2020/01/14181428676115.shtml",
    "datetime": "2020-01-14 18:14:23",
    "code": "002262"
  },
  {
    "title": "恩华药业：盐酸戊乙奎醚注射液3个规格药品获得注册批件",
    "href": "http://stock.jrj.com.cn/2020/01/14161728675510.shtml",
    "datetime": "2020-01-14 16:17:20",
    "code": "002262"
  },
  {
    "title": "恩华药业：盐酸戊乙奎醚注射液3个规格药品获注册批件",
    "href": "http://stock.jrj.com.cn/2020/01/14160128675460.shtml",
    "datetime": "2020-01-14 16:01:00",
    "code": "002262"
  },
  {
    "title": "[恩华药业]恩华药业荣膺“中国上市公司百强排行榜”",
    "href": "http://stock.jrj.com.cn/2019/12/25000028583932.shtml",
    "datetime": "2019-12-25 00:00:00",
    "code": "002262"
  },
  {
    "title": "南京医药：拟逾7200万元收购恩华药业等持有的恩华和润70%股权",
    "href": "http://stock.jrj.com.cn/2019/11/29173828469227.shtml",
    "datetime": "2019-11-29 17:38:00",
    "code": "002262"
  },
  {
    "title": "恩华药业：拟转让控股子公司恩华和润56%股权",
    "href": "http://stock.jrj.com.cn/2019/11/29163428468876.shtml",
    "datetime": "2019-11-29 16:34:27",
    "code": "002262"
  },
  {
    "title": "[恩华药业]我公司“利培酮分散片”首家通过一致性评价",
    "href": "http://stock.jrj.com.cn/2019/11/20000028425553.shtml",
    "datetime": "2019-11-20 00:00:00",
    "code": "002262"
  },
  {
    "title": "恩华药业：利培酮分散片首家通过一致性评价",
    "href": "http://stock.jrj.com.cn/2019/11/19170528419351.shtml",
    "datetime": "2019-11-19 17:05:18",
    "code": "002262"
  },
  {
    "title": "[恩华药业]我公司“氯氮平片”通过一致性评价",
    "href": "http://stock.jrj.com.cn/2019/11/08000028371184.shtml",
    "datetime": "2019-11-08 00:00:00",
    "code": "002262"
  },
  {
    "title": "恩华药业旗下氯氮平片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2019/11/07115428364933.shtml",
    "datetime": "2019-11-07 11:54:05",
    "code": "002262"
  },
  {
    "title": "午间公告：大北农10月生猪销售收入环比增11%；恩华药业氯氮平片通过一致性评价",
    "href": "http://stock.jrj.com.cn/2019/11/07115428364930.shtml",
    "datetime": "2019-11-07 11:54:00",
    "code": "002262"
  },
  {
    "title": "恩华药业三季度净利5.21亿 同比增长23%",
    "href": "http://stock.jrj.com.cn/2019/10/22195528284321.shtml",
    "datetime": "2019-10-22 19:55:16",
    "code": "002262"
  },
  {
    "title": "恩华药业：2019年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/10/22165028283196.shtml",
    "datetime": "2019-10-22 16:50:00",
    "code": "002262"
  },
  {
    "title": "恩华药业前三季度净利润同比增长23.34%",
    "href": "http://stock.jrj.com.cn/2019/10/22161228282969.shtml",
    "datetime": "2019-10-22 16:12:14",
    "code": "002262"
  },
  {
    "title": "[恩华药业]我公司获批“江苏省中枢神经药物研究重点实验室”",
    "href": "http://stock.jrj.com.cn/2019/10/11000028231967.shtml",
    "datetime": "2019-10-11 00:00:00",
    "code": "002262"
  },
  {
    "title": "上市公司晚间利空公告汇总：FDA对恩华药业原料药检查出具警告信",
    "href": "http://stock.jrj.com.cn/2019/09/26180728185434.shtml",
    "datetime": "2019-09-26 18:07:50",
    "code": "002262"
  },
  {
    "title": "恩华药业：美国FDA对公司原料药检查出具警告信",
    "href": "http://stock.jrj.com.cn/2019/09/26174728185358.shtml",
    "datetime": "2019-09-26 17:47:00",
    "code": "002262"
  },
  {
    "title": "恩华药业：FDA对公司原料药检查出具警告信",
    "href": "http://stock.jrj.com.cn/2019/09/26174328185313.shtml",
    "datetime": "2019-09-26 17:43:36",
    "code": "002262"
  },
  {
    "title": "恩华药业2名股东合计增持31万股 耗资约360万元",
    "href": "http://stock.jrj.com.cn/2019/09/24203028174366.shtml",
    "datetime": "2019-09-24 20:30:40",
    "code": "002262"
  },
  {
    "title": "恩华药业今日跌停 公司董事长和总经理跌停价增持31.35万股",
    "href": "http://stock.jrj.com.cn/2019/09/24174928173614.shtml",
    "datetime": "2019-09-24 17:49:00",
    "code": "002262"
  },
  {
    "title": "恩华药业：董事长及总经理合计增持31.35万股",
    "href": "http://stock.jrj.com.cn/2019/09/24173928173557.shtml",
    "datetime": "2019-09-24 17:39:35",
    "code": "002262"
  },
  {
    "title": "恩华药业：获董事长及董事（总经理）合计增持31.35万股",
    "href": "http://stock.jrj.com.cn/2019/09/24172028173454.shtml",
    "datetime": "2019-09-24 17:20:27",
    "code": "002262"
  },
  {
    "title": "恩华药业股东段保州减持2万股 套现约32万元",
    "href": "http://stock.jrj.com.cn/2019/08/29090628053626.shtml",
    "datetime": "2019-08-29 09:06:42",
    "code": "002262"
  },
  {
    "title": "恩华药业：2019年半年度报告主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/07/30205027905323.shtml",
    "datetime": "2019-07-30 20:50:01",
    "code": "002262"
  },
  {
    "title": "恩华药业上半年净利润同比增长22.87%",
    "href": "http://stock.jrj.com.cn/2019/07/30185027904967.shtml",
    "datetime": "2019-07-30 18:50:12",
    "code": "002262"
  },
  {
    "title": "恩华药业：2019年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/07/30185027904960.shtml",
    "datetime": "2019-07-30 18:50:00",
    "code": "002262"
  },
  {
    "title": "恩华药业：上半年净利3.22亿元 同比增长23%",
    "href": "http://stock.jrj.com.cn/2019/07/30181127904786.shtml",
    "datetime": "2019-07-30 18:11:31",
    "code": "002262"
  },
  {
    "title": "恩华药业：上半年净利3.22亿元 同比增23%",
    "href": "http://stock.jrj.com.cn/2019/07/30174927904666.shtml",
    "datetime": "2019-07-30 17:49:00",
    "code": "002262"
  },
  {
    "title": "恩华药业2019年上半年净利3.22亿 改进工艺降低物料消耗",
    "href": "http://stock.jrj.com.cn/2019/07/30172527904453.shtml",
    "datetime": "2019-07-30 17:25:00",
    "code": "002262"
  },
  {
    "title": "恩华药业股东恩华投资质押3300万股 公司去年净利同比增长33%",
    "href": "http://stock.jrj.com.cn/2019/07/13082427835975.shtml",
    "datetime": "2019-07-13 08:24:00",
    "code": "002262"
  },
  {
    "title": "[恩华药业]恩华药业子公司恩元生物与赛默飞达成战略合作",
    "href": "http://stock.jrj.com.cn/2019/07/02000027786704.shtml",
    "datetime": "2019-07-02 00:00:00",
    "code": "002262"
  },
  {
    "title": "恩华药业股东恩华投资合计质押1.27亿股 去年营收同比增长14%",
    "href": "http://stock.jrj.com.cn/2019/06/28075027767785.shtml",
    "datetime": "2019-06-28 07:50:25",
    "code": "002262"
  },
  {
    "title": "恩华药业股东恩华投资质押6150万股 公司去年净利同比增长33%",
    "href": "http://stock.jrj.com.cn/2019/06/12082327692514.shtml",
    "datetime": "2019-06-12 08:23:23",
    "code": "002262"
  },
  {
    "title": "恩华药业：公司制剂产品未对美国出口",
    "href": "http://stock.jrj.com.cn/2019/05/27140327626579.shtml",
    "datetime": "2019-05-27 14:03:00",
    "code": "002262"
  },
  {
    "title": "恩华药业2019年第一季度净利1.26亿元 董事长孙彭生持股4880万股",
    "href": "http://stock.jrj.com.cn/2019/04/20175627434646.shtml",
    "datetime": "2019-04-20 17:56:56",
    "code": "002262"
  },
  {
    "title": "恩华药业：2019年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/04/19160027428928.shtml",
    "datetime": "2019-04-19 16:00:02",
    "code": "002262"
  },
  {
    "title": "[恩华药业]恩华药业、天境生物与Biodextris及美国一流学术医疗中心达成战略合作",
    "href": "http://stock.jrj.com.cn/2019/04/09000027353798.shtml",
    "datetime": "2019-04-09 00:00:00",
    "code": "002262"
  },
  {
    "title": "[恩华药业]省税务局深入企业调研减税降费政策落实情况",
    "href": "http://stock.jrj.com.cn/2019/04/04000027359458.shtml",
    "datetime": "2019-04-04 00:00:00",
    "code": "002262"
  },
  {
    "title": "[恩华药业]你是星星,我是月亮 ——恩华药业与你同行",
    "href": "http://stock.jrj.com.cn/2019/04/03000027313817.shtml",
    "datetime": "2019-04-03 00:00:00",
    "code": "002262"
  },
  {
    "title": "恩华药业：公司目前无工业大麻概念",
    "href": "http://stock.jrj.com.cn/2019/03/25133127227900.shtml",
    "datetime": "2019-03-25 13:31:16",
    "code": "002262"
  },
  {
    "title": "[恩华药业]公司荣获“2018年纳税特别贡献奖”",
    "href": "http://stock.jrj.com.cn/2019/03/22000027208083.shtml",
    "datetime": "2019-03-22 00:00:00",
    "code": "002262"
  },
  {
    "title": "恩华药业：阿芬太尼预计今年申报生产",
    "href": "http://stock.jrj.com.cn/2019/03/06085627124940.shtml",
    "datetime": "2019-03-06 08:56:00",
    "code": "002262"
  },
  {
    "title": "恩华药业：2019年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/02/27164027097664.shtml",
    "datetime": "2019-02-27 16:40:00",
    "code": "002262"
  },
  {
    "title": "[恩华药业]我公司利培酮片通过一致性评价",
    "href": "http://stock.jrj.com.cn/2019/02/21000027071142.shtml",
    "datetime": "2019-02-21 00:00:00",
    "code": "002262"
  },
  {
    "title": "午间公告集锦:恩华药业利培酮片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2019/02/19121227061988.shtml",
    "datetime": "2019-02-19 12:12:18",
    "code": "002262"
  },
  {
    "title": "恩华药业：利培酮片通过一致性评价 用于治疗精神分裂症等症状",
    "href": "http://stock.jrj.com.cn/2019/02/19120127061981.shtml",
    "datetime": "2019-02-19 12:01:00",
    "code": "002262"
  },
  {
    "title": "[恩华药业]恩华子公司徐州颐和医药有限公司成立",
    "href": "http://stock.jrj.com.cn/2018/12/27000026813497.shtml",
    "datetime": "2018-12-27 00:00:00",
    "code": "002262"
  },
  {
    "title": "恩华药业4+7带量采购失意 股价两个月跌幅近半",
    "href": "http://stock.jrj.com.cn/2018/12/14004026737350.shtml",
    "datetime": "2018-12-14 00:40:11",
    "code": "002262"
  },
  {
    "title": "午间公告集锦：多只医药股回应带量采购影响",
    "href": "http://stock.jrj.com.cn/2018/12/10121025493209.shtml",
    "datetime": "2018-12-10 12:10:18",
    "code": "002262"
  },
  {
    "title": "恩华药业：采取加快新品研发等方法应对带量采购影响",
    "href": "http://stock.jrj.com.cn/2018/12/10120825493178.shtml",
    "datetime": "2018-12-10 12:08:37",
    "code": "002262"
  },
  {
    "title": "早间公告：恩华药业否认出口芬太尼",
    "href": "http://stock.jrj.com.cn/2018/12/03083725438875.shtml",
    "datetime": "2018-12-03 08:37:58",
    "code": "002262"
  },
  {
    "title": "[恩华药业]我公司8个产品荣获“2018江苏省医药行业优秀产品品牌”",
    "href": "http://stock.jrj.com.cn/2018/12/03000026818341.shtml",
    "datetime": "2018-12-03 00:00:00",
    "code": "002262"
  },
  {
    "title": "[恩华药业]恩华药业关爱社会福利院孤儿",
    "href": "http://stock.jrj.com.cn/2018/11/23000026813501.shtml",
    "datetime": "2018-11-23 00:00:00",
    "code": "002262"
  },
  {
    "title": "[恩华药业]苏州恩华医药研究有限公司在苏州工业园区生物医药产业园正式揭幕",
    "href": "http://stock.jrj.com.cn/2018/11/19000026813500.shtml",
    "datetime": "2018-11-19 00:00:00",
    "code": "002262"
  },
  {
    "title": "[恩华药业]公司子公司江苏恩华络康药物研发有限公司重庆分公司成立",
    "href": "http://stock.jrj.com.cn/2018/11/14000026813498.shtml",
    "datetime": "2018-11-14 00:00:00",
    "code": "002262"
  },
  {
    "title": "恩华药业：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/10/22195025239094.shtml",
    "datetime": "2018-10-22 19:50:00",
    "code": "002262"
  },
  {
    "title": "恩华药业股东徐州恩华投资补充质押800万股 占比2.26%",
    "href": "http://stock.jrj.com.cn/2018/10/21081325231846.shtml",
    "datetime": "2018-10-21 08:13:00",
    "code": "002262"
  },
  {
    "title": "[恩华药业]公司子公司上海恩元生物科技有限公司在上海成立",
    "href": "http://stock.jrj.com.cn/2018/10/16000025209932.shtml",
    "datetime": "2018-10-16 00:00:00",
    "code": "002262"
  },
  {
    "title": "“带量采购”新政出台 恩华药业核心产品承压",
    "href": "http://stock.jrj.com.cn/2018/09/25052425132554.shtml",
    "datetime": "2018-09-25 05:24:09",
    "code": "002262"
  },
  {
    "title": "恩华药业获董事长及总经理增持股份",
    "href": "http://stock.jrj.com.cn/2018/09/18170125108646.shtml",
    "datetime": "2018-09-18 17:01:03",
    "code": "002262"
  },
  {
    "title": "恩华药业单周股价大跌近两成 迎300多人调研团",
    "href": "http://stock.jrj.com.cn/2018/09/17070825098303.shtml",
    "datetime": "2018-09-17 07:08:10",
    "code": "002262"
  },
  {
    "title": "带量采购政策受关注 恩华药业迎逾300人调研",
    "href": "http://stock.jrj.com.cn/2018/09/17014925097228.shtml",
    "datetime": "2018-09-17 01:49:54",
    "code": "002262"
  },
  {
    "title": "恩华药业因药品带量采购引259家机构关注",
    "href": "http://stock.jrj.com.cn/2018/09/17002025097106.shtml",
    "datetime": "2018-09-17 00:20:17",
    "code": "002262"
  },
  {
    "title": "带量采购引发恩华药业近三日跌去两成 机构博弈激烈",
    "href": "http://stock.jrj.com.cn/2018/09/14170025092963.shtml",
    "datetime": "2018-09-14 17:00:00",
    "code": "002262"
  },
  {
    "title": "恩华药业两日大跌近两成 300多名分析师参会讨论带量采购",
    "href": "http://stock.jrj.com.cn/2018/09/14153025092649.shtml",
    "datetime": "2018-09-14 15:30:00",
    "code": "002262"
  },
  {
    "title": "恩华药业：控股子公司氟曲马唑乳膏获药品注册批件",
    "href": "http://stock.jrj.com.cn/hotstock/2018/09/14075925090449.shtml",
    "datetime": "2018-09-14 07:59:56",
    "code": "002262"
  },
  {
    "title": "恩华药业：控股子公司获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2018/09/13191025088586.shtml",
    "datetime": "2018-09-13 19:10:00",
    "code": "002262"
  },
  {
    "title": "恩华药业控股子公司获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2018/09/13182825088453.shtml",
    "datetime": "2018-09-13 18:28:39",
    "code": "002262"
  },
  {
    "title": "带量采购清单重创医药股 恩华药业连续两日跌停",
    "href": "http://stock.jrj.com.cn/2018/09/13101925085607.shtml",
    "datetime": "2018-09-13 10:19:37",
    "code": "002262"
  },
  {
    "title": "白马股全线杀跌 恩华药业封跌停",
    "href": "http://stock.jrj.com.cn/2018/09/12133225081495.shtml",
    "datetime": "2018-09-12 13:32:42",
    "code": "002262"
  },
  {
    "title": "恩华药业：上半年业绩稳健增长 增长明显",
    "href": "http://stock.jrj.com.cn/2018/09/12091025080109.shtml",
    "datetime": "2018-09-12 09:10:00",
    "code": "002262"
  },
  {
    "title": "恩华药业：二线品种发力助业绩加速增长",
    "href": "http://stock.jrj.com.cn/2018/08/22102324985012.shtml",
    "datetime": "2018-08-22 10:23:00",
    "code": "002262"
  },
  {
    "title": "恩华药业：2018年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/08/19181024970912.shtml",
    "datetime": "2018-08-19 18:10:00",
    "code": "002262"
  },
  {
    "title": "恩华药业：2018年半年度报告主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/08/19163024970781.shtml",
    "datetime": "2018-08-19 16:30:01",
    "code": "002262"
  },
  {
    "title": "恩华药业：业绩符合预期 研发布局力度加大",
    "href": "http://stock.jrj.com.cn/2018/07/27101724871062.shtml",
    "datetime": "2018-07-27 10:17:00",
    "code": "002262"
  },
  {
    "title": "恩华药业：舒芬太尼拟纳入优先审评",
    "href": "http://stock.jrj.com.cn/2018/07/18142924833049.shtml",
    "datetime": "2018-07-18 14:29:00",
    "code": "002262"
  },
  {
    "title": "[恩华药业]江苏恩华药业股份有限公司与徐州医科大学签订校企战略合作协议",
    "href": "http://stock.jrj.com.cn/2018/07/18000026813499.shtml",
    "datetime": "2018-07-18 00:00:00",
    "code": "002262"
  },
  {
    "title": "恩华药业大股东质押3200万股公司股票",
    "href": "http://stock.jrj.com.cn/2018/06/19132424695454.shtml",
    "datetime": "2018-06-19 13:24:00",
    "code": "002262"
  },
  {
    "title": "抓住回调企稳后的低吸机会 恩华药业等10只个股被机构集中推荐",
    "href": "http://stock.jrj.com.cn/2018/05/28000024595965.shtml",
    "datetime": "2018-05-28 00:00:30",
    "code": "002262"
  },
  {
    "title": "恩华药业：股权激励为公司成长再添助力",
    "href": "http://stock.jrj.com.cn/2018/05/25092824589346.shtml",
    "datetime": "2018-05-25 09:28:00",
    "code": "002262"
  },
  {
    "title": "恩华药业与Trevena公司签署《药品许可及合作协议》",
    "href": "http://stock.jrj.com.cn/2018/05/03132124486521.shtml",
    "datetime": "2018-05-03 13:21:00",
    "code": "002262"
  },
  {
    "title": "恩华药业：2018年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/04/24174024441989.shtml",
    "datetime": "2018-04-24 17:40:00",
    "code": "002262"
  },
  {
    "title": "恩华药业通过高新技术企业复审",
    "href": "http://stock.jrj.com.cn/2018/04/04130124350813.shtml",
    "datetime": "2018-04-04 13:01:00",
    "code": "002262"
  },
  {
    "title": "恩华药业：加强研发提升未来发展空间",
    "href": "http://stock.jrj.com.cn/2018/03/02091224178911.shtml",
    "datetime": "2018-03-02 09:12:00",
    "code": "002262"
  },
  {
    "title": "[恩华药业]2017年度国家技术创新示范企业",
    "href": "http://stock.jrj.com.cn/2017/11/30000023720603.shtml",
    "datetime": "2017-11-30 00:00:00",
    "code": "002262"
  },
  {
    "title": "恩华药业上修前三季度业绩预告",
    "href": "http://stock.jrj.com.cn/2017/09/29165423189618.shtml",
    "datetime": "2017-09-29 16:54:37",
    "code": "002262"
  },
  {
    "title": "“两会”窗口期市场风格在切换 9家券商集中推荐恩华药业等个股",
    "href": "http://stock.jrj.com.cn/2017/03/06105122335618.shtml",
    "datetime": "2017-03-06 10:51:00",
    "code": "002262"
  },
  {
    "title": "恩华药业：与NuvOx公司签署《药品许可及合作协议",
    "href": "http://stock.jrj.com.cn/hotstock/2017/01/05075921927930.shtml",
    "datetime": "2017-01-05 07:59:56",
    "code": "002262"
  },
  {
    "title": "恩华药业与Mapi公司签署《股权认购协议》",
    "href": "http://stock.jrj.com.cn/2016/09/09115021438782.shtml",
    "datetime": "2016-09-09 11:50:59",
    "code": "002262"
  },
  {
    "title": "恩华药业：拟出资500万一设立全资子公司",
    "href": "http://stock.jrj.com.cn/hotstock/2016/05/11075920941308.shtml",
    "datetime": "2016-05-11 07:59:58",
    "code": "002262"
  },
  {
    "title": "恩华药业大宗减持960万股 控股股东半月之内减持5%",
    "href": "http://stock.jrj.com.cn/hotstock/2016/05/09221920934482.shtml",
    "datetime": "2016-05-09 22:19:18",
    "code": "002262"
  },
  {
    "title": "恩华药业遭股东减持957万股 占公司总股本1.97%",
    "href": "http://stock.jrj.com.cn/2016/04/27170920888702.shtml",
    "datetime": "2016-04-27 17:09:48",
    "code": "002262"
  },
  {
    "title": "恩华药业控股股东减持公司1.97%股份",
    "href": "http://stock.jrj.com.cn/2016/04/27170520888690.shtml",
    "datetime": "2016-04-27 17:05:26",
    "code": "002262"
  },
  {
    "title": "恩华药业：拟在徐州市贾汪区设立贾汪分公司",
    "href": "http://stock.jrj.com.cn/hotstock/2015/02/17075918874276.shtml",
    "datetime": "2015-02-17 07:59:56",
    "code": "002262"
  },
  {
    "title": "恩华药业拟定增募资5.5亿 加码主营",
    "href": "http://stock.jrj.com.cn/2014/11/04200918295989.shtml",
    "datetime": "2014-11-04 20:09:15",
    "code": "002262"
  },
  {
    "title": "恩华药业：拟投2040万元合资设立恩华络康子公司",
    "href": "http://stock.jrj.com.cn/hotstock/2014/08/08075917768291.shtml",
    "datetime": "2014-08-08 07:59:47",
    "code": "002262"
  },
  {
    "title": "传闻求证：恩华药业首仿药仍在试验中",
    "href": "http://stock.jrj.com.cn/2013/11/19024316172084.shtml",
    "datetime": "2013-11-19 02:43:31",
    "code": "002262"
  },
  {
    "title": "恩华药业：精神领域新品开启未来更大金矿",
    "href": "http://stock.jrj.com.cn/hotstock/2013/07/11094215514508.shtml",
    "datetime": "2013-07-11 09:42:15",
    "code": "002262"
  },
  {
    "title": "恩华药业获1597万中央预算内资金支持",
    "href": "http://stock.jrj.com.cn/2012/10/12185614507072.shtml",
    "datetime": "2012-10-12 18:56:24",
    "code": "002262"
  },
  {
    "title": "恩华药业:继续看好新产品推动的拐点",
    "href": "http://stock.jrj.com.cn/hotstock/2012/07/25123713912434.shtml",
    "datetime": "2012-07-25 12:37:10",
    "code": "002262"
  },
  {
    "title": "恩华药业目标价26.25元 给予买入评级",
    "href": "http://stock.jrj.com.cn/hotstock/2012/05/09144913052925.shtml",
    "datetime": "2012-05-09 14:49:07",
    "code": "002262"
  },
  {
    "title": "恩华药业：公司暂时未有融资的计划和需求",
    "href": "http://stock.jrj.com.cn/2012/04/06163312677232.shtml",
    "datetime": "2012-04-06 16:33:10",
    "code": "002262"
  },
  {
    "title": "恩华药业：新产品潜力大 高增长无忧",
    "href": "http://stock.jrj.com.cn/hotstock/2011/11/28174611666085.shtml",
    "datetime": "2011-11-28 17:46:15",
    "code": "002262"
  },
  {
    "title": "恩华药业:至今未收到盐酸埃他卡林新药批件",
    "href": "http://stock.jrj.com.cn/2011/09/26184111150873.shtml",
    "datetime": "2011-09-26 18:41:31",
    "code": "002262"
  },
  {
    "title": "恩华药业：业绩将现台阶式增长 “强烈推荐-A”评级",
    "href": "http://stock.jrj.com.cn/hotstock/2011/08/18214310784084.shtml",
    "datetime": "2011-08-18 21:43:33",
    "code": "002262"
  },
  {
    "title": "恩华药业：携手外企剑指癫痫药 推荐评级",
    "href": "http://stock.jrj.com.cn/hotstock/2011/06/02220710121490.shtml",
    "datetime": "2011-06-02 22:07:23",
    "code": "002262"
  },
  {
    "title": "恩华药业：主营稳健增长 期待新产品获批",
    "href": "http://stock.jrj.com.cn/hotstock/2011/03/2821209586005.shtml",
    "datetime": "2011-03-28 21:20:08",
    "code": "002262"
  },
  {
    "title": "恩华药业：充分分享行业机遇",
    "href": "http://stock.jrj.com.cn/hotstock/2010/03/2509117173424.shtml",
    "datetime": "2010-03-25 09:11:26",
    "code": "002262"
  }
]